Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.4 EUR | -0.80% |
|
+2.92% | -33.24% |
24/06 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
17/06 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CYTK Stock
- KK3A Stock
- Revisions Cytokinetics, Incorporated